Interruption of CCL2 Inhibition Enhances Metastatic Disease

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2014-226
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of miR-34b and miR-34c Enhances Α-Synuclein Expression in Parkinson's Disease

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2014English

Inhibition of Stathmin1 Accelerates the Metastatic Process

Cancer Research
Cancer ResearchOncology
2012English

Endobronchial Metastatic Disease.

Thorax
PulmonaryRespiratory Medicine
1982English

The CCL2/CCR2 Axis Enhances Vascular Cell Adhesion Molecule-1 Expression in Human Synovial Fibroblasts

PLoS ONE
Multidisciplinary
2012English

SABR Combats Metastatic Disease

Cancer Discovery
Oncology
2018English

Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer

ESMO Open
Cancer ResearchOncology
2017English

WNT Inhibition Enhances Browning of Mouse Primary White Adipocytes

Adipocyte
HistologyCell Biology
2016English

The Science of Interruption

BMJ Quality and Safety
MedicineHealth Policy
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy